Tango Therapeutics, Inc. Annual Return On Equity in % from 2020 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Tango Therapeutics, Inc. quarterly/annual Return On Equity history and growth rate from 2020 to 2023.
  • Tango Therapeutics, Inc. Return On Equity for the quarter ending June 30, 2024 was -44.7 %, a 0.77% decline year-over-year.
  • Tango Therapeutics, Inc. annual Return On Equity for 2023 was -42 %, a 10.7% decline from 2022.
  • Tango Therapeutics, Inc. annual Return On Equity for 2022 was -37.9 %, a 33.9% decline from 2021.
  • Tango Therapeutics, Inc. annual Return On Equity for 2021 was -28.3 %, a 85.3% increase from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -42 -4.06 -10.7% Jan 1, 2023 Dec 31, 2023
2022 -37.9 -9.6 -33.9% Jan 1, 2022 Dec 31, 2022
2021 -28.3 +164 +85.3% Jan 1, 2021 Dec 31, 2021
2020 -192 Jan 1, 2020 Dec 31, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.